Tenaya Therapeutics, Inc.
TNYA
$1.41
$0.1511.94%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.89% | 16.64% | 20.37% | 12.04% | 11.54% |
| Total Depreciation and Amortization | -1.84% | 23.48% | -4.22% | -3.67% | -3.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.67% | -10.41% | -32.40% | 10.25% | 34.98% |
| Change in Net Operating Assets | 151.93% | 5.61% | -54.40% | -7.60% | -383.89% |
| Cash from Operations | 33.89% | 19.36% | 16.13% | 16.08% | 9.93% |
| Capital Expenditure | -94.52% | 32.09% | 48.22% | -2,200.00% | 64.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.87% | 677.96% | 198.50% | -198.09% | -14.25% |
| Cash from Investing | 15.60% | 596.81% | 194.53% | -198.72% | -13.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 7.46% | 1.62% | -- | -86.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -183.51% | 7.46% | 1.62% | -- | -86.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 721.44% | 263.01% | 89.28% | -828.51% | -147.04% |